534 related articles for article (PubMed ID: 27602665)
1. Adalimumab in Patients with Active Noninfectious Uveitis.
Jaffe GJ; Dick AD; Brézin AP; Nguyen QD; Thorne JE; Kestelyn P; Barisani-Asenbauer T; Franco P; Heiligenhaus A; Scales D; Chu DS; Camez A; Kwatra NV; Song AP; Kron M; Tari S; Suhler EB
N Engl J Med; 2016 Sep; 375(10):932-43. PubMed ID: 27602665
[TBL] [Abstract][Full Text] [Related]
2. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.
Nguyen QD; Merrill PT; Jaffe GJ; Dick AD; Kurup SK; Sheppard J; Schlaen A; Pavesio C; Cimino L; Van Calster J; Camez AA; Kwatra NV; Song AP; Kron M; Tari S; Brézin AP
Lancet; 2016 Sep; 388(10050):1183-92. PubMed ID: 27542302
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III.
Suhler EB; Adán A; Brézin AP; Fortin E; Goto H; Jaffe GJ; Kaburaki T; Kramer M; Lim LL; Muccioli C; Nguyen QD; Van Calster J; Cimino L; Kron M; Song AP; Liu J; Pathai S; Camez A; Schlaen A; van Velthoven MEJ; Vitale AT; Zierhut M; Tari S; Dick AD
Ophthalmology; 2018 Jul; 125(7):1075-1087. PubMed ID: 29429764
[TBL] [Abstract][Full Text] [Related]
4. Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials.
Sheppard J; Joshi A; Betts KA; Hudgens S; Tari S; Chen N; Skup M; Dick AD
JAMA Ophthalmol; 2017 Jun; 135(6):511-518. PubMed ID: 28426849
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
Suhler EB; Jaffe GJ; Fortin E; Lim LL; Merrill PT; Dick AD; Brezin AP; Nguyen QD; Thorne JE; Van Calster J; Cimino L; Adan A; Goto H; Kaburaki T; Kramer M; Vitale AT; Kron M; Song AP; Liu J; Pathai S; Douglas KM; Schlaen A; Muccioli C; Van Velthoven MEJ; Zierhut M; Rosenbaum JT
Ophthalmology; 2021 Jun; 128(6):899-909. PubMed ID: 33157077
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.
Ramanan AV; Dick AD; Jones AP; McKay A; Williamson PR; Compeyrot-Lacassagne S; Hardwick B; Hickey H; Hughes D; Woo P; Benton D; Edelsten C; Beresford MW;
N Engl J Med; 2017 Apr; 376(17):1637-1646. PubMed ID: 28445659
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy.
Letko E; Yeh S; Foster CS; Pleyer U; Brigell M; Grosskreutz CL;
Ophthalmology; 2015 May; 122(5):939-48. PubMed ID: 25638011
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab: A Review in Non-Infectious Non-Anterior Uveitis.
Hoy SM
BioDrugs; 2017 Apr; 31(2):135-142. PubMed ID: 28229433
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab for the treatment of refractory active and inactive non-infectious uveitis.
Lee JT; Yates WB; Rogers S; Wakefield D; McCluskey P; Lim LL
Br J Ophthalmol; 2018 Dec; 102(12):1672-1678. PubMed ID: 29459430
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal Adalimumab in Active Noninfectious Uveitis: A Pilot Study.
Hamam RN; Barikian AW; Antonios RS; Abdulaal MR; Alameddine RM; El Mollayess G; Mansour AM
Ocul Immunol Inflamm; 2016 Jun; 24(3):319-26. PubMed ID: 25549063
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis.
Park SE; Jun JW; Lee DH; Lee SC; Kim M
Yonsei Med J; 2021 Feb; 62(2):177-181. PubMed ID: 33527798
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials.
Suhler EB; Thorne JE; Mittal M; Betts KA; Tari S; Camez A; Bao Y; Joshi A
Ophthalmology; 2017 Dec; 124(12):1799-1807. PubMed ID: 28689898
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA).
Nguyen QD; Merrill PT; Clark WL; Banker AS; Fardeau C; Franco P; LeHoang P; Ohno S; Rathinam SR; Thurau S; Abraham A; Wilson L; Yang Y; Shams N;
Ophthalmology; 2016 Nov; 123(11):2413-2423. PubMed ID: 27692526
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Outcomes of Treatment with Biological Agents in Eyes with Refractory, Active, Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
Al-Janabi A; El Nokrashy A; Sharief L; Nagendran V; Lightman S; Tomkins-Netzer O
Ophthalmology; 2020 Mar; 127(3):410-416. PubMed ID: 31607412
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy.
Moll-Udina A; Miguel Escuder L; Hernanz I; Llorenç V; Fonollosa A; Cordero Coma M; Sainz de la Maza M; Espinosa G; González Guijarro JJ; Lopez Lopez F; Alba-Linero C; Hernández M; Martínez Costa L; Celdrán Vivancos D; Giralt L; Artaraz J; Soler Bartrina P; Jódar Márquez M; García de Vicuña R; Esquinas C; Adán A
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1591-1598. PubMed ID: 32657649
[No Abstract] [Full Text] [Related]
16. Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Dick AD; Tugal-Tutkun I; Foster S; Zierhut M; Melissa Liew SH; Bezlyak V; Androudi S
Ophthalmology; 2013 Apr; 120(4):777-87. PubMed ID: 23290985
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab for Treatment of Noninfectious Uveitis: Immunogenicity and Clinical Relevance of Measuring Serum Drug Levels and Antidrug Antibodies.
Cordero-Coma M; Calleja-Antolín S; Garzo-García I; Nuñez-Garnés AM; Álvarez-Castro C; Franco-Benito M; Ruiz de Morales JG
Ophthalmology; 2016 Dec; 123(12):2618-2625. PubMed ID: 27692527
[TBL] [Abstract][Full Text] [Related]
18. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.
Nussenblatt RB; Peterson JS; Foster CS; Rao NA; See RF; Letko E; Buggage RR
Ophthalmology; 2005 May; 112(5):764-70. PubMed ID: 15878055
[TBL] [Abstract][Full Text] [Related]
19. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
[TBL] [Abstract][Full Text] [Related]
20. Adalimumab in Active and Inactive, Non-Infectious Uveitis: Global Results from the VISUAL I and VISUAL II Trials.
Goto H; Zako M; Namba K; Hashida N; Kaburaki T; Miyazaki M; Sonoda KH; Abe T; Mizuki N; Kamoi K; Brézin AP; Dick AD; Jaffe GJ; Nguyen QD; Inomata N; Kwatra NV; Camez A; Song AP; Kron M; Tari S; Ohno S
Ocul Immunol Inflamm; 2019; 27(1):40-50. PubMed ID: 30015528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
